Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Insulin Secretory Vesicles

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evolving epigenomics of immune cells at single-nucleus resolution in children en route to type 1 diabetes.

Nature communications·2026

Same author

Single-cell RNA-seq analysis of longitudinal CD4<sup>+</sup> T cell samples reveals cell-type-specific changes during early stages of type 1 diabetes.

Genome medicine·2025

Same author

Evolving epigenomics of immune cells in type 1 diabetes at single nuclei resolution.

Research square·2025

Same author

High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes-The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) Study.

The Journal of nutrition·2024

Same author

Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD.

ERJ open research·2023

Same author

Infant Feeding, Gut Permeability, and Gut Inflammation Markers.

Journal of pediatric gastroenterology and nutrition·2023

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Leaking gut in type 1 diabetes.

¹Laboratory for Immunobiology, Department of Viral Diseases and Immunology, National Public Health Institute, Helsinki, Finland. outi.vaarala@ktl.fi

Current Opinion in Gastroenterology

|January 6, 2009

Summary

Type 1 diabetes is linked to a "leaky gut" syndrome, characterized by increased intestinal permeability and inflammation. Addressing gut health may offer new ways to prevent or manage autoimmune diabetes.

Area of Science:

Gastroenterology
Immunology
Endocrinology

Background:

Type 1 diabetes is associated with alterations in the intestinal immune system.
Increased small intestinal permeability is a common finding in children with type 1 diabetes.

Purpose of the Study:

To review recent research on the gut-type 1 diabetes connection.
To explore novel pathogenic pathways and prevention strategies for type 1 diabetes.

Main Methods:

Review of recent scientific literature.
Analysis of studies on intestinal permeability and autoimmune diabetes.

Main Results:

Increased intestinal permeability and zonulin levels are observed in type 1 diabetes patients and prediabetic individuals with beta-cell autoimmunity.

More Related Videos

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Lepr^db Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Staining Protocols for Human Pancreatic Islets

Staining Protocols for Human Pancreatic Islets

Published on: May 23, 2012

Related Experiment Videos

Last Updated: Jun 26, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Lepr^db Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Staining Protocols for Human Pancreatic Islets

Staining Protocols for Human Pancreatic Islets

Published on: May 23, 2012

Intestinal permeability and inflammation appear to precede and contribute to beta-cell destruction.

Interventions reducing gut permeability, like zonulin agonists, may prevent diabetes development in animal models.

Conclusions:

A 'leaky gut' syndrome with subclinical inflammation is linked to type 1 diabetes and beta-cell autoimmunity.
Modulating intestinal permeability shows promise in preventing autoimmune diabetes in animal models.
The intestinal environment plays a critical role in the pathogenesis of type 1 diabetes.